Meeting People Where They Are: The Roles of Peer Navigation and Telemedicine for Hepatitis C Virus Elimination.
作者信息
Akiyama Matthew J, Thornton Karla, Voyles Nick, Vincent Louise
机构信息
Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
出版信息
Clin Infect Dis. 2025 Mar 17;80(3):509-511. doi: 10.1093/cid/ciae521.
Abstract
摘要
相似文献
1
Meeting People Where They Are: The Roles of Peer Navigation and Telemedicine for Hepatitis C Virus Elimination.在人们所处的地方与他们相遇：同伴导航和远程医疗在丙型肝炎病毒消除中的作用。
Clin Infect Dis. 2025 Mar 17;80(3):509-511. doi: 10.1093/cid/ciae521.
2
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.全球注射吸毒流行状况以及注射吸毒者的社会人口学特征和艾滋病毒、乙肝病毒及丙肝病毒流行状况：多阶段系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
3
Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling.丙型肝炎病毒在注射吸毒人群中的生物行为学调查——对反应驱动抽样理论假设敏感性的系统评价。
Harm Reduct J. 2017 Jul 11;14(1):44. doi: 10.1186/s12954-017-0172-z.
4
A decentralized point of service triple prevention and treatment model for hepatitis B, C and HIV in people who inject drugs in South Africa.南非针对注射吸毒者的分散式乙肝、丙肝和艾滋病毒服务点三重防治模式
Int J Drug Policy. 2025 Jun 26;143:104894. doi: 10.1016/j.drugpo.2025.104894.
5
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation.干预措施以提高注射毒品人群中丙型肝炎的治疗衔接和治疗依从性：来自专家小组咨询的系统评价和实际考虑。
Int J Drug Policy. 2022 Apr;102:103588. doi: 10.1016/j.drugpo.2022.103588. Epub 2022 Jan 29.
6
Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review.全球、区域和国家层面在注射吸毒人群中开展 HIV 和丙型肝炎感染检测和治疗的情况：系统评价。
Lancet Glob Health. 2023 Dec;11(12):e1885-e1898. doi: 10.1016/S2214-109X(23)00461-8.
7
A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You're Empowered for Treatment Initiation (YETI) partner trial.针对注射吸毒者的丙型肝炎病毒治疗同伴导航单中心随机对照试验：“你有能力开始治疗”（YETI）同伴试验的研究方案
Trials. 2025 Jan 22;26(1):26. doi: 10.1186/s13063-024-08662-0.
8
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.全球、区域和国家层面预防和管理注射吸毒人群中艾滋病毒和丙型肝炎的干预措施的覆盖情况：系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1208-e1220. doi: 10.1016/S2214-109X(17)30373-X. Epub 2017 Oct 23.
9
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis.注射吸毒者中丙型肝炎病毒（HCV）感染发病率以及每年因注射吸毒导致的新增HCV感染病例数的全球、区域和国家估计：一项多阶段分析
Lancet Gastroenterol Hepatol. 2025 Apr;10(4):315-331. doi: 10.1016/S2468-1253(24)00442-4. Epub 2025 Feb 21.
10
Peer-Assisted Telemedicine for Hepatitis C in People Who Use Drugs: A Randomized Controlled Trial.同伴辅助远程医疗用于药物使用者丙型肝炎治疗：一项随机对照试验
Clin Infect Dis. 2025 Mar 17;80(3):501-508. doi: 10.1093/cid/ciae520.
本文引用的文献
1
Expanding Hepatitis C Virus Treatment in the New Mexico State Prison System: Using the ECHO Model for Provider and Prison Peer Education.在新墨西哥州监狱系统中扩大丙型肝炎病毒治疗：利用 ECHO 模型进行提供者和监狱同伴教育。
J Viral Hepat. 2024 Nov;31(11):720-728. doi: 10.1111/jvh.13997. Epub 2024 Aug 13.
2
Can you be a peer if you don't share the same health or social conditions? A qualitative study on peer integration in a primary care setting.如果你没有相同的健康或社会状况，你能成为同伴吗？在初级保健环境中同伴融合的定性研究。
BMC Prim Care. 2024 Aug 12;25(1):298. doi: 10.1186/s12875-024-02548-5.
3
Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial.通过便捷远程医疗实现丙型肝炎与阿片类物质使用障碍的综合治疗：一项随机试验。
JAMA. 2024 Apr 23;331(16):1369-1378. doi: 10.1001/jama.2024.2452.
4
A National Hepatitis C Elimination Program in the United States: A Historic Opportunity.美国的全国丙型肝炎消除计划：一个历史性机遇。
JAMA. 2023 Apr 18;329(15):1251-1252. doi: 10.1001/jama.2023.3692.
5
The Methadone Manifesto: Treatment Experiences and Policy Recommendations From Methadone Patient Activists.《美沙酮宣言：美沙酮患者维权人士的治疗经历与政策建议》
Am J Public Health. 2022 Apr;112(S2):S117-S122. doi: 10.2105/AJPH.2021.306665.
6
Research led by people who use drugs: centering the expertise of lived experience.由吸毒者主导的研究：以生活经验为中心的专业知识。
Subst Abuse Treat Prev Policy. 2021 Sep 20;16(1):70. doi: 10.1186/s13011-021-00406-6.
7
We are the researched, the researchers, and the discounted: The experiences of drug user activists as researchers.我们既是被研究的对象，也是研究人员，还是被低估的人：吸毒者活动家作为研究人员的经历。
Int J Drug Policy. 2021 Dec;98:103364. doi: 10.1016/j.drugpo.2021.103364. Epub 2021 Jul 20.
8
Changing Urban-Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014-2017.2014 - 2017年美国医疗保险患者中丙型肝炎直接抗病毒药物使用方面城乡差距的变化
Am J Prev Med. 2021 Feb;60(2):285-293. doi: 10.1016/j.amepre.2020.08.031. Epub 2020 Nov 19.
9
Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.农村阿片类药物流行所面临的挑战：艾滋病毒和丙型肝炎的治疗和预防。
Curr HIV/AIDS Rep. 2018 Jun;15(3):245-254. doi: 10.1007/s11904-018-0393-0.
10
Outcomes of treatment for hepatitis C virus infection by primary care providers.基层医疗服务提供者治疗丙型肝炎病毒感染的结果。
N Engl J Med. 2011 Jun 9;364(23):2199-207. doi: 10.1056/NEJMoa1009370. Epub 2011 Jun 1.
Zotero 插件